ACTG2 and Megacystis: Genetic testing was performed to rule out megacystis-microcolon syndrome, but specific ACTG2 and MYH11 mutations were not tested due to the limited availability of comprehensive genetic panels, which we recommend for future cases to better characterize the underlying pathophysiology.